Detalles de la búsqueda
1.
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
N Engl J Med
; 386(4): 316-326, 2022 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35081280
2.
Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry.
J Rheumatol
; 51(5): 452-461, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359941
3.
Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry.
Dermatology
; 237(1): 46-55, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-31962340
4.
Exploration of the Product of the 5-Point Investigator's Global Assessment and Body Surface Area (IGA × BSA) as a Practical Minimal Disease Activity Goal in Patients with Moderate-to-Severe Psoriasis.
Dermatology
; 235(4): 348-354, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31141807
5.
Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment.
Pediatr Rheumatol Online J
; 21(1): 129, 2023 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865801
6.
Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database.
Adv Ther
; 39(6): 2932-2945, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482248
7.
Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies.
J Dermatolog Treat
; 33(5): 2614-2620, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385361
8.
Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: Pooled analysis from four phase 3 trials.
J Dermatolog Treat
; 32(7): 709-715, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31873050
9.
Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis.
J Clin Med
; 10(18)2021 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34575192
10.
Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies.
Therap Adv Gastroenterol
; 14: 17562848211054710, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35154388
11.
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift).
RMD Open
; 7(2)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34103405
12.
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis.
RMD Open
; 7(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33452181
13.
Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.
Arthritis Res Ther
; 22(1): 243, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33059710
14.
US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry.
J Dermatolog Treat
; 31(4): 333-341, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31035822
15.
Health Care Utilization and Cost Associated with Biologic Treatment Patterns Among Patients with Moderate to Severe Psoriasis: Analyses from a Large U.S. Claims Database.
J Manag Care Spec Pharm
; 25(4): 479-488, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30556761
Resultados
1 -
15
de 15
1
Próxima >
>>